The management of cancer patients: separate research experiences with gemcitabine HCl and DAB 389 IL-2 fusion protein based on scientific proceedings of an Eli Lilly and Company satellite symposium at the 8th European Conference on Clinical Oncology and Cancer Nursing in Paris, 29 October - 2 November 1995 (Pergamon, 1997)